Alpha-Delta-UA-[1->4]-GLCNS-6S sodium salt, identified by its CAS number 136098-05-0, is a chemically modified glycosaminoglycan derivative. This compound is characterized by its unique structural features, including a specific glycosidic linkage and the presence of sulfate groups, which contribute to its biological activity and solubility in aqueous solutions. It is typically used in various biomedical applications, including drug delivery systems and as a therapeutic agent due to its potential anticoagulant properties. The sodium salt form enhances its stability and solubility, making it suitable for formulation in pharmaceutical products. Additionally, its interactions with proteins and other biomolecules are influenced by its sulfate content, which can affect cell signaling and tissue interactions. Overall, this compound represents a significant area of interest in research focused on glycosaminoglycans and their derivatives, particularly in the context of developing new therapeutic strategies.

ALPHA-DELTA-UA-[1->4]-GLCNS-6S SODIUM SALT

136098-05-0: Heparin Disaccharide Ii-S Sodium Salt, Heparin Disaccharide Ii-S Sodium, (Α-△Ua-[1→4]-Glcns-6S), hexose, 2-deoxy-4-O-(4-deoxyhex-4-enopyranuronosyl)-2-(sulfoamino)-, 6-(hydrogen sulfate), monosodium salt

CAS 136098-05-0: ALPHA-DELTA-UA-[1->4]-GLCNS-6S SODIUM SALT

Heparin disaccharide II-S sodium salt

Ref: 7W-GC8852

Heparin Disaccharide II-S Trisodium Salt

Ref: 4Z-H-026007

Heparin disaccharide II-S trisodium salt

Ref: 3D-OH28907